Publication | Open Access
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
53
Citations
25
References
2019
Year
This study provides technical feasibility data for correlative studies. Tissue biopsies provide distinct data from the blood and may predict response to pembrolizumab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1